---
firstreceived_date: June 8, 2012
is_fda_regulated: 'Yes'
reference: []
overall_contact_backup: {}
completion_date:
  attributes:
    type: Actual
  value: June 2013
responsible_party: {}
firstreceived_results_date: February 4, 2015
is_section_801: 'Yes'
detailed_description: {}
link: []
has_expanded_access: 'No'
id: NCT01645098
intervention:
- intervention_name: Ketamine
  other_name: []
  description: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
  arm_group_label:
  - Dexmedetomidine 1 mcg/kg
  - Dexmedetomidine 0.5 mcg/kg
  intervention_type: Drug
- intervention_name: Dexmedetomidine
  other_name: []
  description: 0.5 mcg/kg/hr IV
  arm_group_label:
  - Dexmedetomidine 1 mcg/kg
  - Dexmedetomidine 0.5 mcg/kg
  intervention_type: Drug
source: Nationwide Children's Hospital
eligibility:
  gender: Male
  maximum_age: N/A
  sampling_method: 
  minimum_age: N/A
  study_pop: {}
  criteria:
    textblock: |-
      Inclusion Criteria:

                -  Patients undergoing a muscle biopsy for IRB11-00203.
  healthy_volunteers: 'No'
removed_countries: {}
other_outcome: []
primary_completion_date:
  attributes:
    type: Actual
  value: April 2013
last_injected: '2015-09-26T09:57:30.835Z'
intervention_browse:
  mesh_term:
  - Dexmedetomidine
target_duration: 
number_of_arms: '2'
start_date: August 2011
why_stopped: 
id_info:
  org_study_id: IRB11-00532
  secondary_id: []
  nct_alias: []
  nct_id: NCT01645098
acronym: 
arm_group:
- description: Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed
    by a continuous infusion of 1 mcg/kg/hr.
  arm_group_label: Dexmedetomidine 1 mcg/kg
  arm_group_type: Experimental
- description: Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed
    by a continuous infusion of 0.5 mcg/kg/hr.
  arm_group_label: Dexmedetomidine 0.5 mcg/kg
  arm_group_type: Experimental
sponsors:
  collaborator: []
  lead_sponsor:
    agency: Nationwide Children's Hospital
    agency_class: Other
secondary_outcome:
- safety_issue: 'Yes'
  time_frame: Baseline to immediately post dexmedetomidine infusion.
  description: Difference in heart rate from baseline to immediately following infusion
    of dexmedetomidine loading dose.
  measure: Heart Rate Change After Dexmedetomidine Loading Dose
- safety_issue: 'Yes'
  time_frame: Baseline to immediately post dexmedetomidine infusion.
  description: Change in MAP from baseline measurement to immediately post dexmedetomidine
    infusion measured via blood pressure cuff.
  measure: Mean Arterial Pressure (MAP) Change After Dexmedetomidine Loading Dose
- safety_issue: 'Yes'
  time_frame: Baseline to immediately post dexmedetomidine infusion.
  description: Change in oxygen saturation from baseline measurement to immediately
    post dexmedetomidine infusion.
  measure: Oxygen Saturation Change After Dexmedetomidine Loading Dose
- safety_issue: 'Yes'
  time_frame: Baseline to immediately post dexmedetomidine infusion.
  description: Change in end-tidal carbon dioxide from baseline measurement to immediately
    post dexmedetomidine infusion.
  measure: EtCO2 Change After Dexmedetomidine Loading Dose
study_type: Interventional
biospec_retention: 
overall_status: Completed
primary_outcome:
- safety_issue: 'No'
  time_frame: Immediately prior to incision
  description: The depth of sedation was judged using the University of Michigan Sedation
    Scale (UMSS). The score ranges from zero, awake and alert, to four, unarousable.
    A score of three, deeply sedated, or more was considered to be an appropriate
    level of sedation for the procedure.
  measure: Time to Sedation Score of 3-4
overall_official:
- first_name: 
  last_name: Joseph D Tobias, MD
  middle_name: 
  affiliation: Nationwide Children's Hospital
  degrees: 
  role: Principal Investigator
phase: N/A
location_countries:
  country:
  - United States
condition:
- Duchenne Muscular Dystrophy
clinical_results:
  limitations_and_caveats: 
  baseline:
    measure_list:
      measure:
      - description: 
        category_list:
          category:
          - sub_title: 
            measurement_list:
              measurement:
              - attributes:
                  spread: 
                  group_id: B1
                  lower_limit: 
                  value: '24'
                  upper_limit: 
              - attributes:
                  spread: 
                  group_id: B2
                  lower_limit: 
                  value: '29'
                  upper_limit: 
              - attributes:
                  spread: 
                  group_id: B3
                  lower_limit: 
                  value: '53'
                  upper_limit: 
        title: Number of Participants
        param: Number
        dispersion: 
        units: participants
      - description: 
        category_list:
          category:
          - sub_title: 
            measurement_list:
              measurement:
              - attributes:
                  spread: '1.4'
                  group_id: B1
                  lower_limit: 
                  value: '9.7'
                  upper_limit: 
              - attributes:
                  spread: '1.9'
                  group_id: B2
                  lower_limit: 
                  value: '8.9'
                  upper_limit: 
              - attributes:
                  spread: '1.7'
                  group_id: B3
                  lower_limit: 
                  value: '9.4'
                  upper_limit: 
        title: Age
        param: Mean
        dispersion: Standard Deviation
        units: years
      - description: 
        category_list:
          category:
          - sub_title: Female
            measurement_list:
              measurement:
              - attributes:
                  spread: 
                  group_id: B1
                  lower_limit: 
                  value: '0'
                  upper_limit: 
              - attributes:
                  spread: 
                  group_id: B2
                  lower_limit: 
                  value: '0'
                  upper_limit: 
              - attributes:
                  spread: 
                  group_id: B3
                  lower_limit: 
                  value: '0'
                  upper_limit: 
          - sub_title: Male
            measurement_list:
              measurement:
              - attributes:
                  spread: 
                  group_id: B1
                  lower_limit: 
                  value: '24'
                  upper_limit: 
              - attributes:
                  spread: 
                  group_id: B2
                  lower_limit: 
                  value: '29'
                  upper_limit: 
              - attributes:
                  spread: 
                  group_id: B3
                  lower_limit: 
                  value: '53'
                  upper_limit: 
        title: Gender
        param: Number
        dispersion: 
        units: participants
    group_list:
      group:
      - attributes:
          group_id: B1
        description: |-
          Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
          Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
          Dexmedetomidine: 0.5 mcg/kg/hr IV
        title: Dexmedetomidine 1 mcg/kg
      - attributes:
          group_id: B2
        description: |-
          Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
          Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
          Dexmedetomidine: 0.5 mcg/kg/hr IV
        title: Dexmedetomidine 0.5 mcg/kg
      - attributes:
          group_id: B3
        description: Total of all reporting groups
        title: Total
    population: 
  point_of_contact:
    name_or_title: Marco Corridore, MD
    email: Marco.Corridore@nationwidechildrens.org
    phone: 614-722-4200
    organization: Nationwide Children's Hospital
  reported_events: {}
  certain_agreements:
    restrictive_agreement: There is NOT an agreement between Principal Investigators
      and the Sponsor (or its agents) that restricts the PI's rights to discuss or
      publish trial results after the trial is completed.
    pi_employee: All Principal Investigators ARE employed by the organization sponsoring
      the study.
  outcome_list:
    outcome:
    - description: The depth of sedation was judged using the University of Michigan
        Sedation Scale (UMSS). The score ranges from zero, awake and alert, to four,
        unarousable. A score of three, deeply sedated, or more was considered to be
        an appropriate level of sedation for the procedure.
      title: Time to Sedation Score of 3-4
      safety_issue: 'No'
      time_frame: Immediately prior to incision
      group_list:
        group:
        - attributes:
            group_id: O1
          description: |-
            Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 1 mcg/kg
        - attributes:
            group_id: O2
          description: |-
            Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 0.5 mcg/kg
      analysis_list: {}
      posting_date: 
      measure_list:
        measure:
        - description: 
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: 
                    group_id: O1
                    lower_limit: 
                    value: '24'
                    upper_limit: 
                - attributes:
                    spread: 
                    group_id: O2
                    lower_limit: 
                    value: '29'
                    upper_limit: 
          title: Number of Participants
          param: Number
          dispersion: 
          units: participants
        - description: The depth of sedation was judged using the University of Michigan
            Sedation Scale (UMSS). The score ranges from zero, awake and alert, to
            four, unarousable. A score of three, deeply sedated, or more was considered
            to be an appropriate level of sedation for the procedure.
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: '2.3'
                    group_id: O1
                    lower_limit: 
                    value: '3.7'
                    upper_limit: 
                - attributes:
                    spread: '1.6'
                    group_id: O2
                    lower_limit: 
                    value: '2.8'
                    upper_limit: 
          title: Time to Sedation Score of 3-4
          param: Mean
          dispersion: Standard Deviation
          units: minutes
      type: Primary
      population: 
    - description: Difference in heart rate from baseline to immediately following
        infusion of dexmedetomidine loading dose.
      title: Heart Rate Change After Dexmedetomidine Loading Dose
      safety_issue: 'Yes'
      time_frame: Baseline to immediately post dexmedetomidine infusion.
      group_list:
        group:
        - attributes:
            group_id: O1
          description: |-
            Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 1 mcg/kg
        - attributes:
            group_id: O2
          description: |-
            Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 0.5 mcg/kg
      analysis_list: {}
      posting_date: 
      measure_list:
        measure:
        - description: 
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: 
                    group_id: O1
                    lower_limit: 
                    value: '24'
                    upper_limit: 
                - attributes:
                    spread: 
                    group_id: O2
                    lower_limit: 
                    value: '29'
                    upper_limit: 
          title: Number of Participants
          param: Number
          dispersion: 
          units: participants
        - description: Difference in heart rate from baseline to immediately following
            infusion of dexmedetomidine loading dose.
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: '13'
                    group_id: O1
                    lower_limit: 
                    value: "-13"
                    upper_limit: 
                - attributes:
                    spread: '10'
                    group_id: O2
                    lower_limit: 
                    value: "-5"
                    upper_limit: 
          title: Heart Rate Change After Dexmedetomidine Loading Dose
          param: Mean
          dispersion: Standard Deviation
          units: BPM
      type: Secondary
      population: 
    - description: Change in MAP from baseline measurement to immediately post dexmedetomidine
        infusion measured via blood pressure cuff.
      title: Mean Arterial Pressure (MAP) Change After Dexmedetomidine Loading Dose
      safety_issue: 'Yes'
      time_frame: Baseline to immediately post dexmedetomidine infusion.
      group_list:
        group:
        - attributes:
            group_id: O1
          description: |-
            Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 1 mcg/kg
        - attributes:
            group_id: O2
          description: |-
            Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 0.5 mcg/kg
      analysis_list: {}
      posting_date: 
      measure_list:
        measure:
        - description: 
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: 
                    group_id: O1
                    lower_limit: 
                    value: '24'
                    upper_limit: 
                - attributes:
                    spread: 
                    group_id: O2
                    lower_limit: 
                    value: '29'
                    upper_limit: 
          title: Number of Participants
          param: Number
          dispersion: 
          units: participants
        - description: Change in MAP from baseline measurement to immediately post
            dexmedetomidine infusion measured via blood pressure cuff.
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: '10'
                    group_id: O1
                    lower_limit: 
                    value: '9'
                    upper_limit: 
                - attributes:
                    spread: '8'
                    group_id: O2
                    lower_limit: 
                    value: '5'
                    upper_limit: 
          title: Mean Arterial Pressure (MAP) Change After Dexmedetomidine Loading
            Dose
          param: Mean
          dispersion: Standard Deviation
          units: mmHg
      type: Secondary
      population: 
    - description: Change in oxygen saturation from baseline measurement to immediately
        post dexmedetomidine infusion.
      title: Oxygen Saturation Change After Dexmedetomidine Loading Dose
      safety_issue: 'Yes'
      time_frame: Baseline to immediately post dexmedetomidine infusion.
      group_list:
        group:
        - attributes:
            group_id: O1
          description: |-
            Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 1 mcg/kg
        - attributes:
            group_id: O2
          description: |-
            Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 0.5 mcg/kg
      analysis_list: {}
      posting_date: 
      measure_list:
        measure:
        - description: 
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: 
                    group_id: O1
                    lower_limit: 
                    value: '24'
                    upper_limit: 
                - attributes:
                    spread: 
                    group_id: O2
                    lower_limit: 
                    value: '29'
                    upper_limit: 
          title: Number of Participants
          param: Number
          dispersion: 
          units: participants
        - description: Change in oxygen saturation from baseline measurement to immediately
            post dexmedetomidine infusion.
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: '1.2'
                    group_id: O1
                    lower_limit: 
                    value: "-0.3"
                    upper_limit: 
                - attributes:
                    spread: '0.7'
                    group_id: O2
                    lower_limit: 
                    value: '0.4'
                    upper_limit: 
          title: Oxygen Saturation Change After Dexmedetomidine Loading Dose
          param: Mean
          dispersion: Standard Deviation
          units: percentage of oxygen
      type: Secondary
      population: 
    - description: Change in end-tidal carbon dioxide from baseline measurement to
        immediately post dexmedetomidine infusion.
      title: EtCO2 Change After Dexmedetomidine Loading Dose
      safety_issue: 'Yes'
      time_frame: Baseline to immediately post dexmedetomidine infusion.
      group_list:
        group:
        - attributes:
            group_id: O1
          description: |-
            Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 1 mcg/kg
        - attributes:
            group_id: O2
          description: |-
            Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
            Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
            Dexmedetomidine: 0.5 mcg/kg/hr IV
          title: Dexmedetomidine 0.5 mcg/kg
      analysis_list: {}
      posting_date: 
      measure_list:
        measure:
        - description: 
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: 
                    group_id: O1
                    lower_limit: 
                    value: '24'
                    upper_limit: 
                - attributes:
                    spread: 
                    group_id: O2
                    lower_limit: 
                    value: '29'
                    upper_limit: 
          title: Number of Participants
          param: Number
          dispersion: 
          units: participants
        - description: Change in end-tidal carbon dioxide from baseline measurement
            to immediately post dexmedetomidine infusion.
          category_list:
            category:
            - sub_title: 
              measurement_list:
                measurement:
                - attributes:
                    spread: '5'
                    group_id: O1
                    lower_limit: 
                    value: '1'
                    upper_limit: 
                - attributes:
                    spread: '6'
                    group_id: O2
                    lower_limit: 
                    value: '2'
                    upper_limit: 
          title: EtCO2 Change After Dexmedetomidine Loading Dose
          param: Mean
          dispersion: Standard Deviation
          units: mmHg
      type: Secondary
      population: 
  participant_flow:
    period_list:
      period:
      - drop_withdraw_reason_list: {}
        milestone_list:
          milestone:
          - participants_list:
              participants:
              - attributes:
                  count: '24'
                  group_id: P1
              - attributes:
                  count: '29'
                  group_id: P2
            title: STARTED
          - participants_list:
              participants:
              - attributes:
                  count: '24'
                  group_id: P1
              - attributes:
                  count: '29'
                  group_id: P2
            title: COMPLETED
          - participants_list:
              participants:
              - attributes:
                  count: '0'
                  group_id: P1
              - attributes:
                  count: '0'
                  group_id: P2
            title: NOT COMPLETED
        title: Overall Study
    recruitment_details: 
    pre_assignment_details: 
    group_list:
      group:
      - attributes:
          group_id: P1
        description: |-
          Patients receive a loading dose of dexmedetomidine 1 mcg/kg followed by a continuous infusion of 1 mcg/kg/hr.
          Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
          Dexmedetomidine: 0.5 mcg/kg/hr IV
        title: Dexmedetomidine 1 mcg/kg
      - attributes:
          group_id: P2
        description: |-
          Patients receive a loading dose of dexmedetomidine 0.5 mcg/kg followed by a continuous infusion of 0.5 mcg/kg/hr.
          Ketamine: 1 mg/kg IV, additional doses of 0.5 mg/kg as needed
          Dexmedetomidine: 0.5 mcg/kg/hr IV
        title: Dexmedetomidine 0.5 mcg/kg
study_design: 'Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy
  Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose:
  Treatment'
keyword: []
results_reference: []
oversight_info:
  has_dmc: 'No'
  authority:
  - 'United States: Institutional Review Board'
number_of_groups: 
location:
- status: 
  contact_backup: {}
  facility:
    name: Nationwide Children's Hospital
    address:
      city: Columbus
      state: Ohio
      zip: '43205'
      country: United States
  investigator: []
  contact: {}
  geodata:
    latitude: 39.961
    formatted: Columbus, OH, USA
    longitude: -82.999
    original: Columbus, Ohio
official_title: Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
verification_date: February 2015
required_header:
  url: https://clinicaltrials.gov/show/NCT01645098
  link_text: Link to the current ClinicalTrials.gov record.
overall_contact: {}
brief_title: Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
biospec_descr: {}
condition_browse:
  mesh_term:
  - Muscular Dystrophies
  - Muscular Dystrophy, Duchenne
brief_summary:
  textblock: |-
    This is an interventional study on Duchenne muscular dystrophy patients who will be
          receiving sedation for a muscle biopsy as part of another study.
enrollment:
  attributes:
    type: Actual
  value: '53'
lastchanged_date: February 25, 2015
